Guangdong Zhongsheng Pharmaceutical (002317) Stock Overview
Guangdong Zhongsheng Pharmaceutical Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
002317 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Competitors
Zhejiang Jiuzhou Pharmaceutical
Guangdong Taienkang Pharmaceutical
Shanghai Shyndec Pharmaceutical
Nanjing King-Friend Biochemical PharmaceuticalLtd
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥17.96 |
| 52 Week High | CN¥24.92 |
| 52 Week Low | CN¥9.85 |
| Beta | 0.55 |
| 1 Month Change | 3.10% |
| 3 Month Change | 8.00% |
| 1 Year Change | 35.85% |
| 3 Year Change | -7.33% |
| 5 Year Change | 44.96% |
| Change since IPO | 79.22% |
Recent News & Updates
Recent updates
We Think You Can Look Beyond Guangdong Zhongsheng Pharmaceutical's (SZSE:002317) Lackluster Earnings
Nov 04
Investor Optimism Abounds Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SZSE:002317) But Growth Is Lacking
Oct 07These 4 Measures Indicate That Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Is Using Debt Reasonably Well
Jul 12Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s (SZSE:002317) P/E Is On The Mark
Jun 18Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Has Affirmed Its Dividend Of CN¥0.20
May 20We Think You Can Look Beyond Guangdong Zhongsheng Pharmaceutical's (SZSE:002317) Lackluster Earnings
Apr 29Does Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Have A Healthy Balance Sheet?
Mar 18Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s (SZSE:002317) Shares Climb 29% But Its Business Is Yet to Catch Up
Feb 29Shareholder Returns
| 002317 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 2.9% | -0.6% | 3.2% |
| 1Y | 35.9% | 16.8% | 22.8% |
Return vs Industry: 002317 exceeded the CN Pharmaceuticals industry which returned 16.8% over the past year.
Return vs Market: 002317 exceeded the CN Market which returned 22.8% over the past year.
Price Volatility
| 002317 volatility | |
|---|---|
| 002317 Average Weekly Movement | 7.8% |
| Pharmaceuticals Industry Average Movement | 5.0% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in CN Market | 9.3% |
| 10% least volatile stocks in CN Market | 3.0% |
Stable Share Price: 002317's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 002317's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 1,775 | Yong Hong Chen | www.zspcl.com |
Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China. The company offers traditional Chinese medicine and chemical medicine. It also focuses on the fields of cardiovascular, respiratory, ophthalmology, and digestive.
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Fundamentals Summary
| 002317 fundamental statistics | |
|---|---|
| Market cap | CN¥15.17b |
| Earnings (TTM) | -CN¥198.67m |
| Revenue (TTM) | CN¥2.40b |
Is 002317 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002317 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.40b |
| Cost of Revenue | CN¥1.09b |
| Gross Profit | CN¥1.31b |
| Other Expenses | CN¥1.51b |
| Earnings | -CN¥198.67m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Oct 31, 2025
| Earnings per share (EPS) | -0.24 |
| Gross Margin | 54.45% |
| Net Profit Margin | -8.27% |
| Debt/Equity Ratio | 10.3% |
How did 002317 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/25 19:24 |
| End of Day Share Price | 2025/10/24 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jie Yao | Everbright Securities Co. Ltd. |
| Yi Yao | Huatai Research |
| Jiaxi Xu | Industrial Securities Co. Ltd. |